These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6757996)

  • 1. [Clinical indicators related to "shock" doses of imipramine in endogenous depressive syndromes].
    Strzyzewski W; Rajewski A; Rozek B; Szajnerman Z; Rajewska J; Rybakowski J
    Psychiatr Pol; 1982; 16(3):121-7. PubMed ID: 6757996
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled double blind comparative study of single dose administration of imipramine pamoate and divided dose of imipramine hydrochloride in depressive illness.
    Khorana AB
    Indian J Physiol Pharmacol; 1981; 25(4):331-8. PubMed ID: 7042559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of antidepressant trials: clinical and research implications.
    Donovan SJ; Quitkin FM; Stewart JW; Ocepek-Welikson K; Harrison W; McGrath PJ; Nunes EV; Wager S; Tricamo E
    J Clin Psychopharmacol; 1994 Feb; 14(1):64-6. PubMed ID: 8151005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative safety of single versus divided dose imipramine in adolescent major depression.
    Ryan ND; Puig-Antich J; Cooper TB; Rabinovich H; Ambrosini P; Fried J; Davies M; Torres D; Suckow RF
    J Am Acad Child Adolesc Psychiatry; 1987 May; 26(3):400-6. PubMed ID: 3597296
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical management--imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program.
    Fawcett J; Epstein P; Fiester SJ; Elkin I; Autry JH
    Psychopharmacol Bull; 1987; 23(2):309-24. PubMed ID: 3303100
    [No Abstract]   [Full Text] [Related]  

  • 7. Escalating imipramine dosage requirements.
    Hudson CJ; Bell HE
    Psychiatr J Univ Ott; 1986 Mar; 11(1):26-7. PubMed ID: 3517915
    [No Abstract]   [Full Text] [Related]  

  • 8. A follow-up report and double blind comparative study of amoxapine and imipramine for the treatment of depressive inpatients.
    Eilenberg MD
    N Z Med J; 1982 Mar; 95(704):189-91. PubMed ID: 7045745
    [No Abstract]   [Full Text] [Related]  

  • 9. Imipramine-related tinnitus.
    Laird LK; Lydiard RB
    J Clin Psychiatry; 1989 Apr; 50(4):146. PubMed ID: 2647714
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial with oxytryptan in depressions].
    Ruiz Ruiz M; Herrera D; Buil R; Lafuente M; Samada P; Zeledón F; Lillo JL
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1981; 9(4):325-30. PubMed ID: 7032243
    [No Abstract]   [Full Text] [Related]  

  • 11. Lithium and imipramine in the prophylaxis of unipolar and bipolar II depression: a prospective, placebo-controlled comparison [proceedings].
    Quitkin FM; Kane JM; Rifkin A; Ramos-Lorenzi JR; Saraf K; Howard A; Klein DF
    Psychopharmacol Bull; 1981 Jan; 17(1):142-4. PubMed ID: 7015396
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of a standardized documentation system (BLIPS/BDP) in the conduct of a multicenter international trial comparing fluvoxamine, imipramine, and placebo.
    Cassano GB; Conti L; Massimetti G; Mengali F; Waekelin JS; Levine J
    Psychopharmacol Bull; 1986; 22(1):52-8. PubMed ID: 3088668
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disorders of vegetative regulation in endogenous depression].
    Strzyzewski W; Gielnik A
    Psychiatr Pol; 1983; 17(1):71-5. PubMed ID: 6353460
    [No Abstract]   [Full Text] [Related]  

  • 16. The Pisa syndrome (pleurothotonus) during antidepressant therapy.
    Suzuki T; Kurita H; Hori T; Sasaki M; Baba A; Shiraishi H; Piletz JE
    Biol Psychiatry; 1997 Jan; 41(2):234-6. PubMed ID: 9018396
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma concentrations of imipramine and clinical response among depressed outpatients.
    Matuzas W; Javaid JI; Glass R; Davis JM; Ross JA; Uhlenhuth EH
    J Clin Psychopharmacol; 1982 Apr; 2(2):140-2. PubMed ID: 7042772
    [No Abstract]   [Full Text] [Related]  

  • 18. [The circulatory system in patients with depression during treatment with antidepressive drugs. II. Effect of therapeutic doses of thymoleptics on ECG records in patients with endogenous depression].
    Rajewska J
    Psychiatr Pol; 1985; 19(4):278-84. PubMed ID: 3832130
    [No Abstract]   [Full Text] [Related]  

  • 19. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP; Galinowski A; Lehert P; Lemonnier F; Lôo H
    Encephale; 1993; 19(4):333-40. PubMed ID: 8275921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of estrogen to imipramine in female-resistant depressives.
    Zohar J; Shapira B; Oppenheim G; Ayd FJ; Belmaker RH
    Psychopharmacol Bull; 1985; 21(3):705-6. PubMed ID: 4034887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.